Clinical Liver Disease
Treatment options for anti-HCV treatment-experienced patients, Peter Ferenci - Article Reading
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:08:06
- More information
Informações:
Synopsis
Treatment failure with pegylated interferon (PEG-IFN)/ribavirin (RBV) dual therapy can be due to either the persistence of hepatitis C virus (HCV) RNA throughout treatment (nonresponse) or the reappearance of the virus after the end of treatment.